TreeWAS – Variant ID: rs1135642

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
N17.9 Acute renal failure, unspecified	0.054	0.946
N17 Acute renal failure	0.051	0.949
N17-N19 Renal failure	0.049	0.951
N19 Unspecified renal failure	0.048	0.952
N18 Chronic renal failure	0.046	0.954
N18.4 Chronic kidney disease, stage 4	0.043	0.957
N18.3 Chronic kidney disease, stage 3	0.041	0.959
N17.8 Other acute renal failure	0.040	0.960
N17.2 Acute renal failure with medullary necrosis	0.037	0.963
N17.1 Acute renal failure with acute cortical necrosis	0.037	0.963
N18.9 Chronic renal failure, unspecified	0.036	0.964
N18.5 Chronic kidney disease, stage 5	0.035	0.965
N17.0 Acute renal failure with tubular necrosis	0.033	0.966
L40.5 Arthropathic psoriasis	0.033	0.967
N18.1 Chronic kidney disease, stage 1	0.033	0.967
N18.0 End-stage renal disease	0.033	0.967
L40 Psoriasis	0.033	0.967
L40.9 Psoriasis, unspecified	0.032	0.968
N18.8 Other chronic renal failure	0.030	0.969
L40-L45 Papulosquamous disorders	0.027	0.973
L43 Lichen planus	0.025	0.975
L40.8 Other psoriasis	0.024	0.976
L40.4 Guttate psoriasis	0.024	0.976
L40.3 Pustulosis palmaris et plantaris	0.024	0.976
L40.2 Acrodermatitis continua	0.024	0.976
L40.1 Generalised pustular psoriasis	0.024	0.976
L43.9 Lichen planus, unspecified	0.023	0.977
L40.0 Psoriasis vulgaris	0.022	0.978
L57.0 Actinic keratosis	0.022	0.978
L42 Pityriasis rosea	0.021	0.978
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.020	0.980
L44 Other papulosquamous disorders	0.020	0.980
L41 Parapsoriasis	0.020	0.980
L45 Papulosquamous disorders in diseases classified elsewhere	0.020	0.980
T43.0 Tricyclic and tetracyclic antidepressants	0.020	0.980
N18.2 Chronic kidney disease, stage 2	0.019	0.981
I67.9 Cerebrovascular disease, unspecified	0.018	0.982
L43.8 Other lichen planus	0.018	0.982
L43.3 Subacute (active) lichen planus	0.018	0.982
L43.2 Lichenoid drug reaction	0.018	0.982
L43.1 Bullous lichen planus	0.018	0.982
L43.0 Hypertrophic lichen planus	0.018	0.982
T43.5 Other and unspecified antipsychotics and neuroleptics	0.018	0.982
T43.2 Other and unspecified antidepressants	0.017	0.983
T43.3 Phenothiazine antipsychotics and neuroleptics	0.016	0.984
L57 Skin changes due to chronic exposure to nonionising radiation	0.016	0.984
T36-T50 Poisoning by drugs, medicaments and biological substances	0.016	0.984
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.015	0.985
T43.9 Psychotropic drug, unspecified	0.014	0.986
T43.8 Other psychotropic drugs, not elsewhere classified	0.014	0.986
T43.6 Psychostimulants with abuse potential	0.014	0.986
T43.4 Butyrophenone and thioxanthene neuroleptics	0.014	0.986
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.014	0.986
L41.9 Parapsoriasis, unspecified	0.014	0.986
L41.8 Other parapsoriasis	0.014	0.986
L41.5 Retiform parapsoriasis	0.014	0.986
L41.4 Large plaque parapsoriasis	0.014	0.986
L41.3 Small plaque parapsoriasis	0.014	0.986
L41.2 Lymphomatoid papulosis	0.014	0.986
L41.1 Pityriasis lichenoides chronica	0.014	0.986
L41.0 Pityriasis lichenoides et varioliformis acuta	0.014	0.986
L44.9 Papulosquamous disorder, unspecified	0.014	0.986
L44.8 Other specified papulosquamous disorders	0.014	0.986
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.014	0.986
L44.3 Lichen ruber moniliformis	0.014	0.986
L44.2 Lichen striatus	0.014	0.986
L44.1 Lichen nitidus	0.014	0.986
L44.0 Pityriasis rubra pilaris	0.014	0.986
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.014	0.986
T46 Poisoning by agents primarily affecting the cardiovascular system	0.013	0.987
T45.0 Antiallergic and antiemetic drugs	0.013	0.987
E11.9 Without complications	0.013	0.987
S52.60 Fracture of lower end of both ulna and radius (closed)	0.013	0.987
E27.8 Other specified disorders of adrenal gland	0.013	0.987
M07.39 Other psoriatic arthropathies (Site unspecified)	0.013	0.987
T36 Poisoning by systemic antibiotics	0.013	0.987
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.012	0.987
E27 Other disorders of adrenal gland	0.012	0.988
E11 Non-insulin-dependent diabetes mellitus	0.012	0.988
E03.9 Hypothyroidism, unspecified	0.012	0.988
Chapter XII Diseases of the skin and subcutaneous tissue	0.012	0.988
E11.2 With renal complications	0.012	0.988
E27.1 Primary adrenocortical insufficiency	0.012	0.988
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.012	0.988
T45.5 Anticoagulants	0.012	0.988
E11.5 With peripheral circulatory complications	0.012	0.988
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.012	0.988
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.011	0.988
L57.5 Actinic granuloma	0.011	0.988
L57.4 Cutis laxa senilis	0.011	0.988
L57.3 Poikiloderma of Civatte	0.011	0.988
L57.2 Cutis rhomboidalis nuchae	0.011	0.988
L57.1 Actinic reticuloid	0.011	0.988
M07.3 Other psoriatic arthropathies	0.012	0.988
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.011	0.988
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.011	0.988
T41 Poisoning by anaesthetics and therapeutic gases	0.011	0.988
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.011	0.988
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.011	0.988
E11.4 With neurological complications	0.011	0.989
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.011	0.989
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.011	0.989
T46.4 Angiotensin-converting-enzyme inhibitors	0.011	0.989
H05.2 Exophthalmic conditions	0.011	0.989
T45.9 Primarily systemic and haematological agent, unspecified	0.011	0.989
T45.8 Other primarily systemic and haematological agents	0.011	0.989
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.011	0.989
T45.6 Fibrinolysis-affecting drugs	0.011	0.989
T45.4 Iron and its compounds	0.011	0.989
T45.3 Enzymes, not elsewhere classified	0.011	0.989
T45.2 Vitamins, not elsewhere classified	0.011	0.989
T45.1 Antineoplastic and immunosuppressive drugs	0.011	0.989
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.010	0.989
T36.0 Penicillins	0.010	0.990
M07.30 Other psoriatic arthropathies (Multiple sites)	0.010	0.990
T40.2 Other opioids	0.010	0.990
L56 Other acute skin changes due to ultraviolet radiation	0.010	0.990
T47.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.010	0.990
L58 Radiodermatitis	0.010	0.990
L55 Sunburn	0.010	0.990
M07.36 Other psoriatic arthropathies (Lower leg)	0.010	0.990
L20-L30 Dermatitis and eczema	0.010	0.990
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.010	0.990
T46.8 Antivaricose drugs, including sclerosing agents	0.010	0.990
T46.7 Peripheral vasodilators	0.010	0.990
T46.5 Other antihypertensive drugs, not elsewhere classified	0.010	0.990
T46.3 Coronary vasodilators, not elsewhere classified	0.010	0.990
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.010	0.990
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.010	0.990
E27.4 Other and unspecified adrenocortical insufficiency	0.010	0.990
I67 Other cerebrovascular diseases	0.010	0.990
E27.2 Addisonian crisis	0.010	0.990
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.010	0.990
E03 Other hypothyroidism	0.010	0.990
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.010	0.990
L29 Pruritus	0.010	0.990
S52.6 Fracture of lower end of both ulna and radius	0.010	0.990
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.010	0.990
L29.9 Pruritus, unspecified	0.010	0.990
F20.0 Paranoid schizophrenia	0.010	0.990
D25.1 Intramural leiomyoma of uterus	0.010	0.990
E11.6 With other specified complications	0.009	0.991
E20-E35 Disorders of other endocrine glands	0.009	0.991
T36.9 Systemic antibiotic, unspecified	0.009	0.991
T36.8 Other systemic antibiotics	0.009	0.991
T36.7 Antifungal antibiotics, systemically used	0.009	0.991
T36.6 Rifamycins	0.009	0.991
T36.5 Aminoglycosides	0.009	0.991
T36.4 Tetracyclines	0.009	0.991
T36.3 Macrolides	0.009	0.991
T36.2 Chloramphenicol group	0.009	0.991
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.009	0.991
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.009	0.991
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.009	0.991
T47.8 Other agents primarily affecting the gastro-intestinal system	0.009	0.991
T47.7 Emetics	0.009	0.991
T47.6 Antidiarrhoeal drugs	0.009	0.991
T47.5 Digestants	0.009	0.991
T47.4 Other laxatives	0.009	0.991
T47.3 Saline and osmotic laxatives	0.009	0.991
T47.2 Stimulant laxatives	0.009	0.991
T47.0 Histamine H(2)-receptor antagonists	0.009	0.991
E27.5 Adrenomedullary hyperfunction	0.009	0.991
E27.3 Drug-induced adrenocortical insufficiency	0.009	0.991
E27.0 Other adrenocortical overactivity	0.009	0.991
E11.7 With multiple complications	0.009	0.991
I67.2 Cerebral atherosclerosis	0.009	0.991
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.009	0.991
T46.1 Calcium-channel blockers	0.009	0.991
L10-L14 Bullous disorders	0.009	0.991
E27.9 Disorder of adrenal gland, unspecified	0.009	0.991
E11.1 With ketoacidosis	0.009	0.991
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.009	0.991
T40.8 Lysergide [LSD]	0.009	0.991
T40.7 Cannabis (derivatives)	0.009	0.991
T40.5 Cocaine	0.009	0.991
T40.3 Methadone	0.009	0.991
T40.1 Heroin	0.009	0.991
T40.0 Opium	0.009	0.991
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.009	0.991
T38.9 Other and unspecified hormone antagonists	0.008	0.991
T38.8 Other and unspecified hormones and their synthetic substitutes	0.008	0.991
T38.7 Androgens and anabolic congeners	0.008	0.991
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.008	0.991
T38.5 Other oestrogens and progestogens	0.008	0.991
T38.4 Oral contraceptives	0.008	0.991
T38.2 Antithyroid drugs	0.008	0.991
T38.1 Thyroid hormones and substitutes	0.008	0.991
T38.0 Glucocorticoids and synthetic analogues	0.008	0.991
M07.38 Other psoriatic arthropathies (Other)	0.008	0.991
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.008	0.991
M07.34 Other psoriatic arthropathies (Hand)	0.008	0.991
M07.33 Other psoriatic arthropathies (Forearm)	0.008	0.991
M07.32 Other psoriatic arthropathies (Upper arm)	0.008	0.991
M07.31 Other psoriatic arthropathies (Shoulder region)	0.008	0.991
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.008	0.991
T37.8 Other specified systemic anti-infectives and antiparasitics	0.008	0.991
T37.5 Antiviral drugs	0.008	0.991
T37.4 Anthelminthics	0.008	0.991
T37.3 Other antiprotozoal drugs	0.008	0.991
T37.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.991
T37.1 Antimycobacterial drugs	0.008	0.991
T37.0 Sulphonamides	0.008	0.991
T41.5 Therapeutic gases	0.008	0.991
T41.4 Anaesthetic, unspecified	0.008	0.991
T41.3 Local anaesthetics	0.008	0.991
T41.2 Other and unspecified general anaesthetics	0.008	0.991
T41.1 Intravenous anaesthetics	0.008	0.991
T41.0 Inhaled anaesthetics	0.008	0.991
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.008	0.991
T48.6 Antiasthmatics, not elsewhere classified	0.008	0.991
T48.5 Anti-common-cold drugs	0.008	0.991
T48.4 Expectorants	0.008	0.991
T48.3 Antitussives	0.008	0.991
T48.2 Other and unspecified agents primarily acting on muscles	0.008	0.991
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.008	0.991
T48.0 Oxytocic drugs	0.008	0.991
T49.9 Topical agent, unspecified	0.008	0.991
T49.8 Other topical agents	0.008	0.991
T49.7 Dental drugs, topically applied	0.008	0.991
T49.6 Otorhinolaryngological drugs and preparations	0.008	0.991
T49.5 Ophthalmological drugs and preparations	0.008	0.991
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.008	0.991
T49.3 Emollients, demulcents and protectants	0.008	0.991
T49.2 Local astringents and local detergents	0.008	0.991
T49.1 Antipruritics	0.008	0.991
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.991
F20 Schizophrenia	0.009	0.991
E00-E07 Disorders of thyroid gland	0.009	0.991
T42.0 Hydantoin derivatives	0.008	0.991
F20.9 Schizophrenia, unspecified	0.008	0.992
E10-E14 Diabetes mellitus	0.008	0.992
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.008	0.992
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.008	0.992
T42.5 Mixed antiepileptics, not elsewhere classified	0.008	0.992
T42.3 Barbiturates	0.008	0.992
T42.2 Succinimides and oxazolidinediones	0.008	0.992
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.008	0.992
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.008	0.992
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.008	0.992
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.008	0.992
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.008	0.992
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.008	0.992
T44.1 Other parasympathomimetics [cholinergics]	0.008	0.992
T44.0 Anticholinesterase agents	0.008	0.992
E28 Ovarian dysfunction	0.008	0.992
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.008	0.992
L50-L54 Urticaria and erythema	0.008	0.992
L28 Lichen simplex chronicus and prurigo	0.008	0.992
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.008	0.992
T50.8 Diagnostic agents	0.008	0.992
T50.7 Analeptics and opioid receptor antagonists	0.008	0.992
T50.6 Antidotes and chelating agents, not elsewhere classified	0.008	0.992
T50.5 Appetite depressants	0.008	0.992
T50.4 Drugs affecting uric acid metabolism	0.008	0.992
T50.3 Electrolytic, caloric and water-balance agents	0.008	0.992
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.008	0.992
T50.1 Loop [high-ceiling] diuretics	0.008	0.992
T50.0 Mineralocorticoids and their antagonists	0.008	0.992
L29.2 Pruritus vulvae	0.008	0.992
T40.6 Other and unspecified narcotics	0.008	0.992
T40.4 Other synthetic narcotics	0.008	0.992
T42.1 Iminostilbenes	0.008	0.992
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.008	0.992
L21 Seborrhoeic dermatitis	0.008	0.992
E34 Other endocrine disorders	0.008	0.992
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.007	0.992
L56.4 Polymorphous light eruption	0.007	0.992
L56.3 Solar urticaria	0.007	0.992
L56.2 Photocontact dermatitis [berloque dermatitis]	0.007	0.992
L56.1 Drug photoallergic response	0.007	0.992
L56.0 Drug phototoxic response	0.007	0.992
E11.8 With unspecified complications	0.007	0.992
E22 Hyperfunction of pituitary gland	0.008	0.992
Chapter IV Endocrine, nutritional and metabolic diseases	0.008	0.992
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.007	0.992
L55.9 Sunburn, unspecified	0.007	0.992
L55.8 Other sunburn	0.007	0.992
L55.2 Sunburn of third degree	0.007	0.992
L55.1 Sunburn of second degree	0.007	0.992
L55.0 Sunburn of first degree	0.007	0.992
L58.9 Radiodermatitis, unspecified	0.007	0.992
L58.1 Chronic radiodermatitis	0.007	0.992
L58.0 Acute radiodermatitis	0.007	0.992
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.007	0.992
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.007	0.992
L59.0 Erythema ab igne [dermatitis ab igne]	0.007	0.992
E24 Cushing's syndrome	0.007	0.992
L25 Unspecified contact dermatitis	0.007	0.993
L24 Irritant contact dermatitis	0.007	0.993
L23 Allergic contact dermatitis	0.007	0.993
L26 Exfoliative dermatitis	0.007	0.993
L22 Diaper [napkin] dermatitis	0.007	0.993
E04.2 Non-toxic multinodular goitre	0.007	0.993
I67.7 Cerebral arteritis, not elsewhere classified	0.007	0.993
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.007	0.993
I67.5 Moyamoya disease	0.007	0.993
I67.4 Hypertensive encephalopathy	0.007	0.993
I67.3 Progressive vascular leukoencephalopathy	0.007	0.993
I67.0 Dissection of cerebral arteries, nonruptured	0.007	0.993
E04 Other non-toxic goitre	0.007	0.993
T39.4 Antirheumatics, not elsewhere classified	0.007	0.993
T39.2 Pyrazolone derivatives	0.007	0.993
E03.5 Myxoedema coma	0.007	0.993
E03.4 Atrophy of thyroid (acquired)	0.007	0.993
E03.3 Postinfectious hypothyroidism	0.007	0.993
E03.1 Congenital hypothyroidism without goitre	0.007	0.993
E03.0 Congenital hypothyroidism with diffuse goitre	0.007	0.993
E11.0 With coma	0.007	0.993
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.007	0.993
T39.0 Salicylates	0.007	0.993
L20 Atopic dermatitis	0.007	0.993
I67.8 Other specified cerebrovascular diseases	0.007	0.993
L29.8 Other pruritus	0.007	0.993
L29.3 Anogenital pruritus, unspecified	0.007	0.993
L29.1 Pruritus scroti	0.007	0.993
S52.61 Fracture of lower end of both ulna and radius (open)	0.007	0.993
S52 Fracture of forearm	0.007	0.993
E35 Disorders of endocrine glands in diseases classified elsewhere	0.007	0.993
E32 Diseases of thymus	0.007	0.993
E31 Polyglandular dysfunction	0.007	0.993
E30 Disorders of puberty, not elsewhere classified	0.007	0.993
E25 Adrenogenital disorders	0.007	0.993
E28.2 Polycystic ovarian syndrome	0.007	0.993
L50 Urticaria	0.007	0.993
E07 Other disorders of thyroid	0.007	0.993
S52.5 Fracture of lower end of radius	0.007	0.993
T39.1 4-Aminophenol derivatives	0.007	0.993
T50.9 Other and unspecified drugs, medicaments and biological substances	0.007	0.993
E13 Other specified diabetes mellitus	0.007	0.993
E20 Hypoparathyroidism	0.007	0.993
S52.50 Fracture of lower end of radius (closed)	0.007	0.993
E22.0 Acromegaly and pituitary gigantism	0.007	0.993
L13 Other bullous disorders	0.006	0.993
L12 Pemphigoid	0.006	0.993
L11 Other acantholytic disorders	0.006	0.993
L10 Pemphigus	0.006	0.993
L14 Bullous disorders in diseases classified elsewhere	0.006	0.993
L29.0 Pruritus ani	0.007	0.993
M07 Psoriatic and enteropathic arthropathies	0.007	0.993
L28.1 Prurigo nodularis	0.006	0.993
E28.3 Primary ovarian failure	0.006	0.993
E23 Hypofunction and other disorders of pituitary gland	0.006	0.993
E29 Testicular dysfunction	0.006	0.994
F20.8 Other schizophrenia	0.006	0.994
F20.6 Simple schizophrenia	0.006	0.994
F20.5 Residual schizophrenia	0.006	0.994
F20.4 Postschizophrenic depression	0.006	0.994
F20.3 Undifferentiated schizophrenia	0.006	0.994
F20.2 Catatonic schizophrenia	0.006	0.994
F20.1 Hebephrenic schizophrenia	0.006	0.994
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.006	0.994
E00 Congenital iodine-deficiency syndrome	0.006	0.994
E02 Subclinical iodine-deficiency hypothyroidism	0.006	0.994
E26 Hyperaldosteronism	0.006	0.994
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994
E03.8 Other specified hypothyroidism	0.006	0.994
L51 Erythema multiforme	0.006	0.994
L50.9 Urticaria, unspecified	0.006	0.994
L21.9 Seborrhoeic dermatitis, unspecified	0.006	0.994
L00-L08 Infections of the skin and subcutaneous tissue	0.006	0.994
E12 Malnutrition-related diabetes mellitus	0.006	0.994
E24.0 Pituitary-dependent Cushing's disease	0.006	0.994
E28.9 Ovarian dysfunction, unspecified	0.006	0.994
E28.8 Other ovarian dysfunction	0.006	0.994
E28.1 Androgen excess	0.006	0.994
E28.0 Oestrogen excess	0.006	0.994
E34.8 Other specified endocrine disorders	0.006	0.994
E34.9 Endocrine disorder, unspecified	0.006	0.994
L54 Erythema in diseases classified elsewhere	0.006	0.994
L28.2 Other prurigo	0.006	0.994
L30 Other dermatitis	0.006	0.994
L50.1 Idiopathic urticaria	0.006	0.994
L21.8 Other seborrhoeic dermatitis	0.006	0.994
L21.1 Seborrhoeic infantile dermatitis	0.006	0.994
L21.0 Seborrhoea capitis	0.006	0.994
E13.9 Without complications	0.006	0.994
E06 Thyroiditis	0.006	0.994
E22.1 Hyperprolactinaemia	0.006	0.994
E04.0 Non-toxic diffuse goitre	0.006	0.994
H05 Disorders of orbit	0.006	0.994
L28.0 Lichen simplex chronicus	0.006	0.994
E34.5 Androgen resistance syndrome	0.006	0.994
E34.4 Constitutional tall stature	0.006	0.994
E34.3 Short stature, not elsewhere classified	0.006	0.994
E34.2 Ectopic hormone secretion, not elsewhere classified	0.006	0.994
E34.1 Other hypersecretion of intestinal hormones	0.006	0.994
E34.0 Carcinoid syndrome	0.006	0.994
E24.9 Cushing's syndrome, unspecified	0.006	0.994
E22.9 Hyperfunction of pituitary gland, unspecified	0.006	0.994
E22.8 Other hyperfunction of pituitary gland	0.006	0.994
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.006	0.994
E24.8 Other Cushing's syndrome	0.005	0.994
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.005	0.994
E24.3 Ectopic ACTH syndrome	0.005	0.994
E24.2 Drug-induced Cushing's syndrome	0.005	0.994
E24.1 Nelson's syndrome	0.005	0.994
B37.0 Candidal stomatitis	0.006	0.994
L23.9 Allergic contact dermatitis, unspecified cause	0.005	0.994
L23.8 Allergic contact dermatitis due to other agents	0.005	0.994
L23.7 Allergic contact dermatitis due to plants, except food	0.005	0.994
L23.6 Allergic contact dermatitis due to food in contact with the skin	0.005	0.994
L23.5 Allergic contact dermatitis due to other chemical products	0.005	0.994
L23.4 Allergic contact dermatitis due to dyes	0.005	0.994
L23.3 Allergic contact dermatitis due to drugs in contact with the skin	0.005	0.994
L23.2 Allergic contact dermatitis due to cosmetics	0.005	0.994
L23.1 Allergic contact dermatitis due to adhesives	0.005	0.994
L23.0 Allergic contact dermatitis due to metals	0.005	0.994
L24.9 Irritant contact dermatitis, unspecified cause	0.005	0.994
L24.8 Irritant contact dermatitis due to other agents	0.005	0.994
L24.7 Irritant contact dermatitis due to plants, except food	0.005	0.994
L24.6 Irritant contact dermatitis due to food in contact with the skin	0.005	0.994
L24.5 Irritant contact dermatitis due to other chemical products	0.005	0.994
L24.4 Irritant contact dermatitis due to drugs in contact with the skin	0.005	0.994
L24.3 Irritant contact dermatitis due to cosmetics	0.005	0.994
L24.2 Irritant contact dermatitis due to solvents	0.005	0.994
L24.1 Irritant contact dermatitis due to oils and greases	0.005	0.994
L24.0 Irritant contact dermatitis due to detergents	0.005	0.994
L25.9 Unspecified contact dermatitis, unspecified cause	0.005	0.994
L25.8 Unspecified contact dermatitis due to other agents	0.005	0.994
L25.5 Unspecified contact dermatitis due to plants, except food	0.005	0.994
L25.4 Unspecified contact dermatitis due to food in contact with the skin	0.005	0.994
L25.3 Unspecified contact dermatitis due to other chemical products	0.005	0.994
L25.2 Unspecified contact dermatitis due to dyes	0.005	0.994
L25.1 Unspecified contact dermatitis due to drugs in contact with the skin	0.005	0.994
L25.0 Unspecified contact dermatitis due to cosmetics	0.005	0.994
S52.7 Multiple fractures of forearm	0.005	0.994
E04.8 Other specified non-toxic goitre	0.005	0.994
E07.9 Disorder of thyroid, unspecified	0.006	0.994
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.006	0.994
E65-E68 Obesity and other hyperalimentation	0.006	0.994
L08 Other local infections of skin and subcutaneous tissue	0.005	0.994
E07.8 Other specified disorders of thyroid	0.005	0.995
L20.8 Other atopic dermatitis	0.005	0.995
L20.0 Besnier's prurigo	0.005	0.995
S52.3 Fracture of shaft of radius	0.005	0.995
E11.3 With ophthalmic complications	0.005	0.995
S52.9 Fracture of forearm, part unspecified	0.005	0.995
S52.4 Fracture of shafts of both ulna and radius	0.005	0.995
S52.1 Fracture of upper end of radius	0.005	0.995
L20.9 Atopic dermatitis, unspecified	0.005	0.995
E25.9 Adrenogenital disorder, unspecified	0.005	0.995
E25.8 Other adrenogenital disorders	0.005	0.995
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.005	0.995
E30.9 Disorder of puberty, unspecified	0.005	0.995
E30.8 Other disorders of puberty	0.005	0.995
E30.1 Precocious puberty	0.005	0.995
E30.0 Delayed puberty	0.005	0.995
E31.9 Polyglandular dysfunction, unspecified	0.005	0.995
E31.8 Other polyglandular dysfunction	0.005	0.995
E31.1 Polyglandular hyperfunction	0.005	0.995
E31.0 Autoimmune polyglandular failure	0.005	0.995
E32.9 Disease of thymus, unspecified	0.005	0.995
E32.8 Other diseases of thymus	0.005	0.995
E32.1 Abscess of thymus	0.005	0.995
E32.0 Persistent hyperplasia of thymus	0.005	0.995
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.005	0.995
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.005	0.995
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.005	0.995
S52.51 Fracture of lower end of radius (open)	0.005	0.995
L50.8 Other urticaria	0.005	0.995
L50.6 Contact urticaria	0.005	0.995
L50.5 Cholinergic urticaria	0.005	0.995
L50.4 Vibratory urticaria	0.005	0.995
L50.3 Dermatographic urticaria	0.005	0.995
L50.2 Urticaria due to cold and heat	0.005	0.995
E07.1 Dyshormogenetic goitre	0.005	0.995
E07.0 Hypersecretion of calcitonin	0.005	0.995
E04.9 Non-toxic goitre, unspecified	0.005	0.995
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.005	0.995
L60-L75 Disorders of skin appendages	0.005	0.995
E13.8 With unspecified complications	0.005	0.995
E13.7 With multiple complications	0.005	0.995
E13.6 With other specified complications	0.005	0.995
E13.5 With peripheral circulatory complications	0.005	0.995
E13.4 With neurological complications	0.005	0.995
E13.3 With ophthalmic complications	0.005	0.995
E13.2 With renal complications	0.005	0.995
E13.1 With ketoacidosis	0.005	0.995
E13.0 With coma	0.005	0.995
E20.8 Other hypoparathyroidism	0.005	0.995
E20.1 Pseudohypoparathyroidism	0.005	0.995
E20.0 Idiopathic hypoparathyroidism	0.005	0.995
E23.0 Hypopituitarism	0.005	0.995
L10.9 Pemphigus, unspecified	0.005	0.995
L10.8 Other pemphigus	0.005	0.995
L10.5 Drug-induced pemphigus	0.005	0.995
L10.4 Pemphigus erythematosus	0.005	0.995
L10.3 Brazilian pemphigus [fogo selvagem]	0.005	0.995
L10.2 Pemphigus foliaceus	0.005	0.995
L10.1 Pemphigus vegetans	0.005	0.995
L10.0 Pemphigus vulgaris	0.005	0.995
L11.9 Acantholytic disorder, unspecified	0.005	0.995
L11.8 Other specified acantholytic disorders	0.005	0.995
L11.1 Transient acantholytic dermatosis [Grover]	0.005	0.995
L11.0 Acquired keratosis follicularis	0.005	0.995
L12.9 Pemphigoid, unspecified	0.005	0.995
L12.8 Other pemphigoid	0.005	0.995
L12.3 Acquired epidermolysis bullosa	0.005	0.995

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations